Results 161 to 170 of about 1,019,369 (340)
Epidemiology of hospitalized heart failure in France based on national data over 10 years, 2012–2022
ESC Heart Failure, Volume 12, Issue 2, Page 1283-1294, April 2025.Abstract Aims We aim to describe the incidence of HF hospitalization in France in the post‐pandemic era, the prevalence of HF cases and patients' characteristics, management and outcomes while focusing on sex, age and socio‐economic differences and to analyse time‐trends between 2012 and 2022.
Valérie Olié +5 more
wiley +1 more source
Catheter Ablation for Atrial Fibrillation Targeting Incremental Left Ventricular Ejection Fraction
, 2021 Mimi Chapman, Teruhiko Imamura
openalex +2 more sources
Considerations for drug trials in hypertrophic cardiomyopathy
ESC Heart Failure, Volume 12, Issue 2, Page 1095-1112, April 2025.Abstract Hypertrophic cardiomyopathy (HCM) is a heterogeneous condition with potentially serious manifestations. Management has traditionally comprised therapies to palliate symptoms and implantable cardioverter‐defibrillators to prevent sudden cardiac death. The need for disease‐modifying therapies has been recognized for decades.
John P. Farrant +17 more
wiley +1 more source
A Case Report of Ventricular Fibrillation Supported by Left Ventricular Assist Device For Hours. [PDF]
Ersin Doğanözü +3 more
openalex +1 more source
Case Report: Hypertrophic cardiomyopathy with recurrent episodes of ventricular fibrillation and concurrent sinus arrest [PDF]
, 2023 Jassin Hamidi +4 more
openalex +1 more source
Prognostic role of TAPSE to PASP ratio in outpatients with left ventricular systolic dysfunction
ESC Heart Failure, Volume 12, Issue 2, Page 912-922, April 2025.Abstract Aims Few data are available regarding the role of tricuspid annulus plane systolic excursion to pulmonary artery systolic pressure (TAPSE/PASP), a measurement of right ventricular to pulmonary artery coupling, in patients with chronic heart failure and left ventricular systolic dysfunction.
Mauro Riccardi +9 more
wiley +1 more source
ESC Heart Failure, Volume 12, Issue 2, Page 1295-1303, April 2025.Abstract Background Obesity is a known risk factor for cardiovascular disease (CVD), yet an ‘obesity paradox’ has been observed in various CVD contexts. The impact of obesity on heart failure (HF) patients treated with a wearable cardioverter‐defibrillator (WCD) remains underexplored.
Mohammad Abumayyaleh +18 more
wiley +1 more source
Molecular Basis of Hypokalemia-Induced Ventricular Fibrillation
Circulation, 2015 A. Pezhouman +11 more
semanticscholar +1 more source
Arrhythmia Diagnosis Following an ICD Shock.
Indian Pacing and Electrophysiology Journal, 2001 Stored electrograms show atrial fibrillation with rapid ventricular rates (top panel). Sufficient numbers of RR intervals meet the tachycardia detection criteria initiating a train of anti-tachycardia pacing by the ICD (after the 8th electrogram in the ...
Roy M. John
doaj